A series of representative benzyloxy substituted MAO-B inhibitors were synthesized and evaluated.
Compounds 5–8, 12–17, 25, 28 and 31 exhibited neuroprotective effects against 6-OHDA- and rotenone-treated PC12 cells.
Compound 13 showed neuroprotective effects against neurotoxins-induced ROS accumulation and apoptosis.
Compound 13 might be promising candidates for the therapy of Parkinson’s disease.